Quantbot Technologies LP Adaptive Biotechnologies Corp Transaction History

Quantbot Technologies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$2.88 - $4.8 $76,245 - $127,075	26,474 New	26,474 $84,000
Q3 2022 Nov 07, 2022	BUY	$6.5 - $12.67 $518,778 - $1.01 Million	79,812 New	79,812 $568,000
Q2 2022 Aug 09, 2022	SELL	$6.4 - $14.73 $196,659 - $452,623	-30,728 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $310,967 - $888,039	30,728 New	30,728 $426,000
Q2 2021 Aug 12, 2021	SELL	$32.22 - $44.59 $347,750 - $481,259	-10,793 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$37.26 - $67.74 $402,147 - $731,117	10,793 New	10,793 $434,000
Q4 2019 Feb 10, 2020	SELL	$24.56 - $32.8 $99,492 - $132,872	-4,051 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$30.31 - $53.51 $122,785 - $216,769	4,051 New	4,051 $125,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.